Envista Holdings Co. (NYSE:NVST – Get Free Report) CFO Eric D. Hammes purchased 24,532 shares of the stock in a transaction dated Monday, August 12th. The stock was bought at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the purchase, the chief financial officer now owns 24,532 shares in the company, valued at $400,607.56. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Envista Trading Up 4.2 %
NYSE NVST opened at $18.03 on Friday. The stock has a market capitalization of $3.10 billion, a price-to-earnings ratio of -25.04, a PEG ratio of 14.74 and a beta of 1.31. Envista Holdings Co. has a 52 week low of $15.15 and a 52 week high of $33.34. The stock’s 50 day moving average price is $16.71 and its two-hundred day moving average price is $19.29. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.93 and a current ratio of 2.27.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). The business had revenue of $633.10 million during the quarter, compared to the consensus estimate of $646.88 million. Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. The business’s revenue for the quarter was down 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.43 EPS. As a group, analysts anticipate that Envista Holdings Co. will post 1.15 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Envista
Analyst Ratings Changes
Several brokerages have commented on NVST. Morgan Stanley downgraded shares of Envista from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $33.00 to $21.00 in a research note on Friday, April 26th. Robert W. Baird lowered their price objective on shares of Envista from $19.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. The Goldman Sachs Group reduced their target price on Envista from $20.00 to $17.50 and set a “sell” rating on the stock in a report on Friday, May 3rd. Piper Sandler lowered their price target on Envista from $18.00 to $16.00 and set a “neutral” rating for the company in a report on Tuesday, July 30th. Finally, JPMorgan Chase & Co. cut Envista from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $19.14.
View Our Latest Stock Report on Envista
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Jeff Brown’s Exegesis AI Stock Picks
- Ride Out The Recession With These Dividend Kings
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.